MLTXMoonLake Immunotherapeutics

MLTX Stock Price, Valuation & Chart | MoonLake Immunotherapeutics

Compare

$15.060-0.07 (-0.46%)

At close · 02 Sept 2026, 08:00 pm

Sector: Healthcare Industry: Biotechnology MLTX intrinsic value MLTX calculated fair value vs price

Overview Financials Dividends Ratios

MLTX Historical price chart

MLTX Key Stats

Fair Value

Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Unlock

Market Capitalization1.27B

PE Ratio-3.89

EPS-3.87

Trading Volume1.19M

Today's High/Low15.45/14.85

Dividend Yield0.00

52 Week High/Low62.75/5.95

Shares Outstanding84.12M

MLTX Financial Statement

MLTX Analyst ratings

MLTX Analysis & performance metrics

MLTX Company profile

MoonLake Immunotherapeutics, a clinical-stage biopharmaceutical company, engages in developing therapies. It is developing Sonelokimab, a novel investigational Nanobody…

MoonLake Immunotherapeutics, a clinical-stage biopharmaceutical company, engages in developing therapies. It is developing Sonelokimab, a novel investigational Nanobody therapy for the treatment of inflammation. The company is involved in conducting Phase II trials for hidradenitis suppurativa, psoriatic arthritis, ankylosing spondylitis, or radiographic axial spondyloarthritis.…

MLTX Management team

Name

Position

Luciana MarquesCTO

Director of HR, People & Culture

Nicolas Mosimann Ph.D.

General Counsel

Tino Anthamatten

Vice President of Marketing, Market Access & Pricing

Nuala Brennan

Chief Clinical Development Officer

Carla BretesCTO

Director of Investor Relations & External Communications

Oliver Daltrop Ph.D.

Chief Operations Officer

Kristian Reich M.D., Ph.D.

Co-Founder & Chief Scientific Officer

Joana CortezCTO

Senior Director Legal & Compliance

Name

Position

Luciana MarquesCTO

Director of HR, People & Culture

Nicolas Mosimann Ph.D.

General Counsel

Tino Anthamatten

Vice President of Marketing, Market Access & Pricing

Nuala Brennan

Chief Clinical Development Officer

Carla BretesCTO

Director of Investor Relations & External Communications

Oliver Daltrop Ph.D.

Chief Operations Officer

Kristian Reich M.D., Ph.D.

Co-Founder & Chief Scientific Officer

Joana CortezCTO

Senior Director Legal & Compliance

Management Team

Luciana MarquesCTO

Director of HR, People & Culture

Nicolas Mosimann Ph.D.

General Counsel

Tino Anthamatten

Vice President of Marketing, Market Access & Pricing

Nuala Brennan

Chief Clinical Development Officer

Carla BretesCTO

Director of Investor Relations & External Communications

Oliver Daltrop Ph.D.

Chief Operations Officer

Kristian Reich M.D., Ph.D.

Co-Founder & Chief Scientific Officer

Joana CortezCTO

Senior Director Legal & Compliance

Management

Luciana MarquesCTO

Director of HR, People & Culture

Nicolas Mosimann Ph.D.

General Counsel

Tino Anthamatten

Vice President of Marketing, Market Access & Pricing

Nuala Brennan

Chief Clinical Development Officer

Carla BretesCTO

Director of Investor Relations & External Communications

Oliver Daltrop Ph.D.

Chief Operations Officer

Kristian Reich M.D., Ph.D.

Co-Founder & Chief Scientific Officer

Joana CortezCTO

Senior Director Legal & Compliance

Total 8 executives

MLTX Frequently asked questions

What is MoonLake Immunotherapeutics (MLTX) Stock Price?

Current stock price of MoonLake Immunotherapeutics (MLTX) stock is $15.060. The stock price is -0.46% lower in the session. The intraday range can be seen from this page. Volume of MoonLake Immunotherapeutics (MLTX) stock is 1.19M.

Last updated at 02 Sept 2026, 08:00 pm.

Why is the MoonLake Immunotherapeutics (MLTX) stock price going up or down today?

The stock price of MoonLake Immunotherapeutics (MLTX) can change with earnings, company news, and overall market sentiment. MoonLake Immunotherapeutics operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the MoonLake Immunotherapeutics stock expensive at its current price?

Whether MoonLake Immunotherapeutics looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for MLTX on this page is -3.89. EPS on this page is -3.87. Compare those figures with peers and growth expectations before deciding if the current MoonLake Immunotherapeutics price is justified.

How has the stock price of MoonLake Immunotherapeutics (MLTX) performed historically?

Historical performance for MoonLake Immunotherapeutics (MLTX) is shown on the price chart on this page. Review multi-period moves alongside volume to see how MLTX reacted to past earnings and market events.

Should I buy MoonLake Immunotherapeutics (MLTX) stock, at this price?

Buying MoonLake Immunotherapeutics (MLTX) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.